Is ALTER.PA a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Theradiag SA (ALTER.PA) is (2.06) EUR. With the latest stock price at 1.26 EUR, the upside of Theradiag SA based on DCF is -263.7%. This means that ALTER.PA is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.7% | 6.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (15.01) - (1.00) | (2.06) |
| Upside | -1290.9% - -179.7% | -263.7% |